In this era of Early Bird Satellite news broadcasts, we have come to worship the "god of speedy communication." The contemporary aim is to vie for the honor of being first in reporting the latest news morsel. The medical equivalent of this trend is the emphasis upon reporting the latest drug, a previously unreported diagnostic technique, or the existence of a rare and enigmatic disease. The ultimate step may well be an international contest to find a cure for which there is no disease.
These somewhat flippant comments are not meant to denigrate the importance of original investigations in the laboratory or at the bedside. We cannot deny, however, that the clamor for editorial priority for the "latest" frequently results in evanescent fads. The relegation of the review article to a second-class editorial status is another serious consequence of this unseemly haste. A thoughtfully prepared review communication serves to synthesize